Dunn Gordon
- SEC CIK
- 0001958139
No open-market purchases or sales filed in the past year.
Current role at each company
- QNRX Quoin Pharmaceuticals Ltd.Chief Financial Officeras of Dec 27, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dunn Gordon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2024 (view filing)5:16 PM ET | Dec 23 | 4 days | Dunn GordonChief Financial Officer | PPurchase | +122.2K | $0.45 | +$55.0K | +423.6%151.1K after | |
| Dec 27, 2024 (view filing)5:16 PM ET | Dec 23 | 4 days | Dunn GordonChief Financial Officer | PPurchaseADS | +244.4K | – | – | –122.2K after | Derivative2 lots |
| Sep 11, 2024 (view filing) | Sep 9-10 | 2 days | Dunn GordonChief Financial Officer | PPurchase | +28.9K | $0.8042 | +$23.2K | New position28.9K after | 5 lots |